A Quality of Life Study Using Insulin Potentiation Targeted LowDose (IPTLD) Chemotherapy and Nutrition Therapy in the Treatment of Cancer

NCT02598479 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2018-08-28

No results posted yet for this study

Summary

The IPTLD QoL Broad Study.

Conditions

Interventions

OTHER

IPTLD and nutrition therapy

The measurement of Quality of Life in patients who choose to use Insulin Potentiation Low Dose Therapy and Nutritional Therapy in the treatment of cancer

Sponsors & Collaborators

  • Best Answer for Cancer Foundation

    lead OTHER

Principal Investigators

  • Martha M Grout, MD, MD(H) · Arizona Center for Advanced Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2018-08-31
Completion
2018-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02598479 on ClinicalTrials.gov